LST1 expression correlates with immune infiltration and predicts poor prognosis in acute myeloid leukemia
Abstract Clinical management of acute myeloid leukemia (AML) poses significant challenges due to its poor prognosis and heterogeneous nature. Discovering new biomarkers is crucial for improving risk assessment and customizing treatment approaches. While leukocyte-specific transcript 1 (LST1) is impl...
Saved in:
| Main Authors: | Haitao Xu, Dangui Chen, Jia Lu, Lihong Wang, Fei Chen, Long Zhong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2025-03-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-025-02082-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Identification and validation of BATF as a prognostic biomarker and regulator of immune cell infiltration in acute myeloid leukemia
by: Zhe Zhao, et al.
Published: (2025-01-01) -
CEBPA mutation in acute myeloid leukemia: prognostic impact of bZIP domain mutation
by: Roy Raj, et al.
Published: (2024-10-01) -
Identification of HOXA9 methylation as an epigenetic biomarker predicting prognosis and guiding treatment choice in acute myeloid leukemia
by: Fei Xie, et al.
Published: (2025-02-01) -
Impact of single nucleotide polymorphisms of immunomodulatory factors on treatment response and prognosis in acute myeloid leukemia
by: Mingying Li, et al.
Published: (2025-03-01) -
High expression of SOX10 is correlated with poor prognosis and immune infiltrates in skin cutaneous melanoma
by: Xu Sun, et al.
Published: (2025-04-01)